Why Biogen Inc. (BIIB) is stock facing headwinds despite recent FDA approval?
Biogen Inc. (BIIB) shares lost 0.01% in after-hours on Thursday, June 24, 2021, and closed the day at $349.13 per share. Earlier in the morning session, BIIB’s stock lost 6.11% to close Thursday’s session at $349.16. BIIB shares have risen 30.19% over the last 12 months, and they have moved down by 8.96% in the […]
